| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 89.7 | 87.0 | 78.0 |
| Other income | 4.1 | 1.0 | 3.2 |
| Total income | 93.9 | 88.0 | 81.2 |
| Profit before exceptional items & tax | 5.0 | -56.9 | -5.2 |
| Exceptional items | 0.0 | 93.0 | 0.0 |
| Profit before tax | 8.2 | 38.6 | -3.5 |
| Net profit | 7.1 | 24.6 | -3.6 |
| Operating margin | 8.7% | 43.9% | -4.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -71.10% |
|---|---|
| Revenue, year on year | +15.00% |
| Operating profit, year on year | +110.70% |
| Operating profit, quarter on quarter | +101.60% |
BSE results filing, NSE: THEMISMED. Figures extracted from the filing.
Themis Medicare Ltd: key numbers
- Share price
- ₹96.49
- Market cap
- ₹888.7 Cr
- Revenue (annual)
- ₹342.2 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- 17.6×Sector 48.6×
- Promoter holding
- 67.11%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Themis Medicare Ltd
All →Themis Medicare Other Announcement
Themis Medicare revised its June 2026 shareholding pattern to recategorise three Vividhmargi Trust trustees as Promoter Group. Total promoter and promoter group holding is unchanged, so this is a routine disclosure.
Themis Medicare Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹89.74 cr (+15.1% YoY), EBITDA ₹5.58 cr (6.2% margin) turned positive, PAT ₹7.06 cr vs prior loss. API rebound and hospital focus.
Themis Medicare Other Announcement
Themis Medicare has filed a revised September 2026 quarter shareholding pattern. It reclassifies trustees as promoter group and adds OSS Software Solutions as a nil-holding promoter group member.
Themis Medicare Board Meeting Date
Themis Medicare's board is scheduled for November 5, 2026, to approve quarterly and half-year financial results. The trading window remains closed until 48 hours post-results publication.
Themis Medicare Share Pledge
Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.
- Value
- ₹135.0 Cr
Themis Medicare Management Change
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.